Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer: In Need of a Blockbuster Drug Now
Motley Fool
Wednesday, August 8, 2012 - 12:02pm
tags:
Pfizer
Charles River Labs 2Q income falls 6 percent
Yahoo/AP
Wednesday, August 8, 2012 - 11:54am
tags:
earnings, Charles River Laboratories
Clovis Oncology Announces Second Quarter 2012 Operating Results
Yahoo
Wednesday, August 8, 2012 - 11:54am
tags:
earnings, Clovis Oncology
Warner Chilcott Ends Sale Effort, Announces Dividend
Bloomberg
Wednesday, August 8, 2012 - 11:53am
tags:
dividends, Warner Chilcott
Antitrust Suit Over Sanofi Vaccine Can Proceed
Pharmalot
Wednesday, August 8, 2012 - 11:52am
tags:
Sanofi, vaccines, antitrust, Novartis, Menactra
Vanda Pharmaceuticals: More Than Enough Cash On Hand To Buy Themselves
Seeking Alpha
Wednesday, August 8, 2012 - 11:33am
tags:
Vanda, Pfizer, Eli Lilly, JNJ, Bristol-Myers Squibb, Acadia
Merck says key data on Zetia cholesterol drug due in 2014
Reuters
Wednesday, August 8, 2012 - 11:14am
tags:
Merck, Zetia
Lilly Last Hope For Alzheimer’s As Pfizer, J&J Bow Out
Bloomberg
Wednesday, August 8, 2012 - 11:01am
tags:
Pfizer, Eli Lilly, JNJ, bapineuzumab, Alzheimer's disease, solanezumab, Baxter International, Gammagard
Lundbeck In Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Wednesday, August 8, 2012 - 10:45am
tags:
Alzheimer's disease, Lundbeck, AE58054
Vivus rises ahead of 2nd-quarter earnings report
Yahoo/AP
Tuesday, August 7, 2012 - 5:58pm
tags:
Vivus, earnings
Achillion announces SVR4 of 85%-100% from trial evaluating sovaprevir
Yahoo/Fly on the Wall
Tuesday, August 7, 2012 - 5:56pm
tags:
Achillion, sovaprevir, hepatitis C
Chelsea Therapeutics Earnings: Loss Narrowed
Wall St. Cheat Sheet
Tuesday, August 7, 2012 - 5:55pm
tags:
earnings, Chelsea Therapeutics
Decision Date for Medivation Drug
Yahoo/Zacks
Tuesday, August 7, 2012 - 5:53pm
tags:
Medivation, Astellas, Enzalutamide, prostate cancer
Endo Health rises on 2Q adjusted income and sales
Yahoo/AP
Tuesday, August 7, 2012 - 1:33pm
tags:
earnings, Endo
Did Ranbaxy give up exclusivity on copycat Provigil?
Fierce Pharma
Tuesday, August 7, 2012 - 1:32pm
tags:
Ranbaxy, Provigil, generics
J&J faces new marketing probes as Risperdal settlement nears
Fierce Pharma
Tuesday, August 7, 2012 - 12:49pm
tags:
JNJ, Risperdal, Doribax, DOJ, Relieva Stratus MicroFlow Spacer
Infinity Pharmaceuticals says reducing headcount by approximately 20%
Yahoo/Fly on the Wall
Tuesday, August 7, 2012 - 12:28pm
tags:
layoffs, Infinity Pharmaceuticals
Cadence Pharmaceuticals' Ofirmev Launch Has Gained Traction: Buy
Seeking Alpha
Tuesday, August 7, 2012 - 12:27pm
tags:
Ofirmev, Cadence Pharmaceuticals, acetaminophen
Arena Set To Show Strong Growth
Seeking Alpha
Tuesday, August 7, 2012 - 12:04pm
tags:
Arena Pharmaceuticals, Orexigen, Vivus, Belviq
Insmed Earnings: Transition is the Key Word, and Investors Don’t Like It
Wall St. Cheat Sheet
Tuesday, August 7, 2012 - 12:03pm
tags:
Insmed, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.